SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 25.19 |
Enterprise Value ($M) | 6.65 |
Book Value ($M) | 64.68 |
Book Value / Share | 6.88 |
Price / Book | 0.39 |
NCAV ($M) | 15.38 |
NCAV / Share | 1.64 |
Price / NCAV | 1.64 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.60 |
Return on Assets (ROA) | -0.49 |
Return on Equity (ROE) | -0.57 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 15.19 |
Current Ratio | 15.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 26.88 |
Assets | 76.19 |
Liabilities | 11.51 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Hirschman Orin | 6.00 | ||
13G | Bank Of America Corp /de/ | 5.30 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,366 | 4,468 | 52.95 | |
2,242 | 10,392 | 21.57 | |
1,800 | 2,209 | 81.48 | |
991 | 306 | 323.86 | |
(click for more detail) |
Similar Companies | |
---|---|
ABVC – ABVC BioPharma, Inc. | ACB – Aurora Cannabis Inc. |
ACHV – Achieve Life Sciences, Inc. | ACXP – Acurx Pharmaceuticals, Inc. |
ADIL – Adial Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io